after 25 years of dedicated research a potential vaccine for type 1 diabetes developed in Finland is headed for human clinical trials by the year 2050 it’s anticipated that in the US alone 5 million people will be diagnosed with type 1 diabetes this autoimmune disease which affects children and adults is currently unable to […]

Continue Reading...